CRANBURY, N.J. and BENGALURU, India, Sept. 10, 2025 /PRNewswire/ — Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, today announced the inauguration of its first U.S. manufacturing facility in Cranbury, New Jersey, by its wholly owned…
